The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34+ cells
| Image |  |
|---|---|
| Description | scientific article published on 15 July 2010 |
| Author/s |
author: Andrew Zannettino Deborah L. White |
| Publication date | July 15, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |